Innovative randomized trial hints at mortality benefits with high-dose influenza vaccines
Physical activity and sedentary behavior both increased during COVID lockdown, new research reveals
29 August 2022Exploring the brief use of rapamycin treatment in early adulthood to extend lifespan
29 August 2022Innovative randomized trial hints at mortality benefits with high-dose influenza vaccines
In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination. The late breaking research was presented in a Hot Line session on 27 August at ESC Congress 2022.
